When you hear people talking about glucagon-like peptide (GLP) 1 receptor agonists or semaglutide, theyre referring to a class of medications that help with type 2 diabetes, weight loss, chronic kidney disease, and more
received grants to the institution from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim and NovoNordisk and speaker and advisor honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Servier and TAD
BMC Complement Med Ther
The processes involve the induction of autophagy, activation of antioxidant capacity in various brain areas, and inhibition of neuroinflammation by inactivating microglia and astrocytes
10.1186/s13578-020-00500-5 63
Our range of GLP-1 friendly shakes offer you nutritionally complete support, plus a range of additional active ingredients to help you achieve your body goals